Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F

  • Daniele Mollaioli,

    Roles Data curation, Formal analysis, Investigation, Software, Validation, Writing – original draft, Writing – review & editing

    Affiliation Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

  • Stefania Di Sante,

    Roles Data curation, Formal analysis, Investigation

    Affiliation Division of Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

  • Erika Limoncin,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing

    Affiliation Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

  • Giacomo Ciocca,

    Roles Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing

    Affiliation Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

  • Giovanni Luca Gravina,

    Roles Formal analysis, Validation

    Affiliation Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

  • Elisa Maseroli,

    Roles Investigation

    Affiliation Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

  • Egidia Fanni,

    Roles Investigation

    Affiliation Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

  • Linda Vignozzi,

    Roles Investigation

    Affiliation Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

  • Mario Maggi,

    Roles Supervision

    Affiliation Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

  • Andrea Lenzi,

    Roles Supervision

    Affiliation Division of Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

  • Emmanuele A. Jannini

    Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

    eajannini@gmail.com

    Current address: Chair of Endocrinology and Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy.

    Affiliation Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

Abstract

The female orgasm represents one of the most complex functions in the field of human sexuality.

The conjunction of the anatomical, physiological, psycho-relational and socio-cultural components contributes to make the female orgasm still partly unclear. The female orgasmic experience, its correlates and the relation with sexual desire, arousal and lubrication as predictors are highly debated in scientific community. In this context, little is known about the impact of female sexual dysfunction (SD) on sexual pleasure expressed by subjective orgasmic intensity, and there are no suitable psychometric tools suited to investigate this dimension. Thus, we validate, in female subjects, a Visual Analogue Scale (VAS) that we named Orgasmometer-F, to verify if SD is accompanied by a lower perceived orgasmic intensity. A total of 526 women, recruited through a web-based platform and from sexological outpatient clinic, were enrolled in the study. They were divided into, on the basis of the Female Sexual Function Index (FSFI) score in two groups: 1) 112women suffering from SD, (SD Group); and 2) 414 sexually healthy women (Control Group). The participants were requested to fill out the Orgasmometer-F, recording orgasmic intensity on a Likert scale from 0 (absence of orgasmic intensity) to 10 (maximum orgasmic intensity experienced). Women with SD experienced significantly lower orgasmic intensity than controls, as measured by the Orgasmometer-F (p < 0.0001). Interestingly, masturbatory frequency was positively correlated with orgasmic intensity, as were the lubrication, orgasm and sexual satisfaction domains of the FSFI. The Orgasmometer-F was well understood, had a good test-retest reliability (ICC = 0.93) and a high AUC in differentiating between women with and without sexual dysfunction (AUC = 0.9; p < 0.0001). The ROC curve analysis showed that a cut-off <5 had 86.5% sensitivity (95% CI 82,8–89,6), 80.4% specificity (95% CI 71.8–87.3), 75.4% positive predictive value (PPV) and 89.5% negative predictive value (NPV). In conclusion, the Orgasmometer-F, a new psychometrically sound tool for measuring orgasmic intensity in female population, demonstrated that SD impair orgasmic intensity.

Introduction

Female orgasm is a neuromuscular phenomenon triggered by sexual (somatic and mental) stimuli, accompanied by anatomical and physiological responses including vasocongestion of the erectile tissues, lubrication, and pelvic contractions that induce intense pleasurable sensations [15]. This female orgasm is not yet fully understood and defined, because of the great variability in factors including localization [68], stimulation techniques [9,10], self-image [1113] and quality of romantic relationship [10,14]. It is therefore very difficult to describe female orgasm simply and concisely. For this reason, the analysis of orgasmic experience in women is not yet complete and merits further investigation of necessary details.

The mechanisms of interaction between the external and internal clitoris and the anatomical structures that contribute to the formation of the orgasmic platform have been described [1]. However, there is also a larger area involved in sexual stimulation, called the clitourethrovaginal (CUV) complex [1517], a variable, multifaceted morpho-functional area that, when properly stimulated during penetration, could induce orgasmic response.

In addition, orgasmic function is strictly related with the other sexual response phases (desire, arousal, lubrication). The capability of reaching a satisfying orgasm needs the ability of having sexual fantasies and partially loosing cognitive control, making the arousal increase and having an efficient lubrication during all the sexual experience. [18,19]

In contrast, little is known about the orgasmic experience, meaning the feelings and cognitions experienced during orgasm. Terms like orgasmic intensity, pleasure and satisfaction should be included in the evaluation of orgasmic experience [20] and related to the different ways of achieving orgasm [21], to its cognitive-affective aspects [22], and to satisfaction with relationship itself [14]. Despite its importance, this aspect is entirely neglected in the investigation of sexual dysfunction, even though for many women orgasm is the ultimate goal of intercourse [23] and a source of sexual satisfaction with or without their partner [10].

A negative or absent orgasmic experience is often related to a general condition of sexual dysfunction [24]. The last Diagnostic and Statistical Manual of Mental Disorders (DSM5) includes in the “Female Orgasmic Disorder" (FOD) both the absence of orgasm (anorgasmia) and the delayed or reduced intensity of orgasm [25]. The female sexual dysfunctions (SD) classified according to medical and psychiatric taxonomies [26,27] induce in the couple a sexual discomfort that affects, to varying degrees, all phases of the sexual response cycle. In fact, a negative orgasmic experience is often both the cause and consequence of difficulties in relation to hypoactive sexual desire disorder, vaginal dryness and inadequate arousal [24,27].

Despite the current debate on female orgasm, the importance of orgasm itself in the couple’s health and the possible impact of reduced or absent orgasmic experience in provoking or amplifying female SD, within the several psychosexological questionnaires mentioning the orgasmic function [2833], none specifically measures the female orgasmic intensity. Previous attempts to assess female orgasm have been focused in assessing the phenomenological sensations (sensory and cognitive-affective), with a two-dimensional model, associated with orgasm (Orgasm Rating Scale) [20] or attempting to capture the specific bodily sensations that are associated with climax (Bodily Sensations of Orgasm questionnaire) [34]. Conversely, a well-validated Visual Analogue Scale (VAS) and named the “Orgasmometer”, is currently available in the clinical andrology to assess, with excellent psychometric qualities, exclusively the intensity of orgasm in male [35].

Thus, the aim of this study was to establish and validate a new psychometric tool, the Orgasmometer-F measuring the orgasmic intensity in a female population with SD.

Material and methods

Study population

A consecutive series of 643 and 35 subjects were enrolled, respectively, through a web-based platform ad hoc build and publicized by social media, or from our sexual medicine outpatient clinic. All the subjects were invited to fill out into the web-based platform a sociodemographic questionnaire exploring clinical and sexual history, the Female Sexual Function Index (FSFI) questionnaire and the Orgasmometer-F (see later).

Based on the presence or absence of reported SD (evaluated by the clinical cut-off of the FSFI questionnaire, i.e.< 26,55) [29], subjects were divided into two groups. The SD Group with pathological FSFI score was composed of 77 women enrolled online (OL-SD subgroup) and 35 women recruited as outpatients with an SD (OP-SD subgroup) and the control group of 414 women with normal FSFI filled out in the web-based platform. The remaining 152 subjects from the web-based platform were excluded from the study on the basis of the exclusion criteria (see below), irrespectively of the FSFI score. (Fig 1)

Among the inclusion criteria, women during the six months preceding the enrollment had to be sexually active and had to have experienced orgasmic pleasure (clitorally and/or vaginally activated [7]). The exclusion criteria (evaluated by the sociodemographic questionnaire) for both groups were as follows: age below 18; menopause or pregnancy; referred presence in women or in their partners of medical conditions influencing orgasmic experience (multiple sclerosis, diabetic nerve damage, spinal cord injury, hormonal disorder, menopause, chronic pelvic pain, and endometriosis) or psychiatric diseases; use of psychiatric medications affecting orgasmic intensity (hypnotics, anxiolytics, antidepressants, antipsychotics); drug use (alpha-sympathetic drugs, opioids, cocaine); absence of orgasmic experience during the last 6 months.

All subjects were asked to inspect all the study information, to give their written informed consent to the use of their personal information and to complete all the questionnaires.

All subjects participated voluntarily. The “Azienda Policlinico Umberto I” Ethics Committee approved the study protocol.

Main outcome measures

The female sexual function index.

This standardized psychometric questionnaire is a validated tool to evaluate the presence of sexual dysfunction [29,30], which has been validated also in Italian language [36]. It has 19item in six domains exploring overall female sexual function, based on the DSM IV-TR criteria [37]. It takes about 15 minutes to complete and the response options for each item are on a 5-6-points Likert scale. Scores below the clinical cut-off point (26.55) indicate the presence of sexual dysfunction in the previous 4 weeks [29].

The Orgasmometer-F.

The Orgasmometer-F is a psychometric tool evaluating the subjective perception of orgasmic intensity (Fig 2). It is structurally based on the Visual Analogue Scale (VAS) [38], a psychometric tool for the evaluation of subjective perception of pain intensity. It was recently validated in men [35]. Orgasmic intensity is reported through both a numeric scale and chromatic gradation, ranging from 0 (white), corresponding to the absence of orgasmic intensity, to 10 (deep red), corresponding to the highest level of orgasmic intensity. Unlike in men, where orgasmic intensity was evaluated for the four weeks preceding test administration, we chosen a 6-months period in order to adhere to DSM criteria of FOD regarding the reduction of orgasmic intensity.

thumbnail
Fig 2. The Orgasmometer-F.

Considering a Likert scale ranging from 0 to 10, where 0 corresponds to the absence of orgasmic perception and 10 to maximum perceived orgasmic intensity, how do you evaluate your orgasmic intensity in the last six months?

https://doi.org/10.1371/journal.pone.0202076.g002

Statistical analysis

In order to verify the distribution (normal or non-normal) of the variables, the Kolmogorov-Smirnov test has been operated for each study variable. Since continuous variables were not normally distributed, Mann-Whitney test for the comparison of independent samples and Spearman’s Rho for the correlation have been performed with a normal distribution were expressed as mean ± standard deviation, whereas non-normally distributed continuous variables were expressed as median (95% CI). Frequencies and percentages were computed for dichotomous variables. Differences in categorical variables were tested for statistical significance with the Chi-squared test. [39]

Orgasmic intensity scores in the study groups [OL-SD vs. OP-SD and SD group vs. control group] were compared by multivariate analysis of covariance (MANCOVA) was performed using relationship status, masturbatory frequency and FSFI domains (desire, arousal, lubrication, orgasm, pain, satisfaction) as covariates. A stepwise multiple regression was used to identify significant determinants of perceived orgasmic intensity.

To compare the predictive ability of the Orgasmometer-F in females with and without sexual dysfunction, receiver-operated characteristic (ROC) curves were used to determine the cut-offs that best discriminated between the individuals with high and low levels of perceived orgasmic intensity. To evaluate specificity and sensitivity, ROC analyses were performed using the method recommended by DeLong et al. [40]. A p value of ≤0.05 was considered as statistically significant for each statistical analysis.

Results

To evaluate reliability, intraclass correlation coefficient (ICC) analysis was performed on Orgasmometer-F repeated measures, collected on day 0 and 14 (n = 35). The ICC was 0.93 (95% CI 0.91–0.95), showing a high test-retest reliability.

As the SD group consisted of two subgroups (OL-SD and OP-SD groups), a MANCOVA analysis adjusted for relationship status, masturbatory frequency and FSFI domains (desire, arousal, lubrication, orgasm, pain, satisfaction) was performed to assess whether they differed in their Orgasmometer-F score, but found no difference (OL-SD: mean: 5.25; 95% CI 4.93–5.58; OP-SD: mean 5.05; 95% CI 4.55–5.56; p = 0.519). The two subgroups were therefore unified and considered as a single SD group.

The socio-demographic and clinical variables of the sample are shown in Table 1. Clinical and demographic variables differ significantly between the SD and control groups, except for age and BMI variables.

A MANCOVA analysis with relationship status, masturbatory frequency and FSFI domains (desire, arousal, lubrication, orgasm, pain, satisfaction) as covariates were therefore performed to assess any differences in the subjective perception of orgasmic intensity between the two groups. The SD group reported lower scores (mean 5.24; 95% CI 4.79–5.69) than the controls (mean 6.71; 95% CI 6.54–6.88; Table 2); this difference was statistically significant (p<0.0001).

thumbnail
Table 2. MANCOVA analysis for SD group and control group Orgasmometer-F values adjusted for covariates.

https://doi.org/10.1371/journal.pone.0202076.t002

Despite significative differences between the two groups in being in a relationship and having an university education, these variables do not impact on the subjective orgasmic intensity, as well for sexual desire, arousal and coital pain domains of FSFI.

As masturbatory frequency, lubrication, orgasmic function and sexual satisfaction were found to be correlated with orgasmic intensity, a stepwise multiple regression analysis was then performed to investigate their relationship with perceived orgasmic intensity. This analysis suggested:

  • a positive correlation between the lubrication FSFI domain score (rpartial = 0.318; p <0.0001) and the Orgasmometer-F score;
  • a positive correlation between the orgasmic FSFI domain score (rpartial = 0.292; p <0.0001) and the Orgasmometer-F score;
  • a positive correlation between the sexual satisfaction FSFI domain score (rpartial = 0.244; p <0.0001) and the Orgasmometer-F score;
  • a positive correlation between the frequency of masturbation (rpartial = 0.137; p = 0.0017) and the Orgasmometer-F score.

Hence, lower scores in lubrication, orgasm and sexual satisfaction, as well as lower masturbation frequency, were associated with a lower subjective perceived orgasmic intensity.

Fig 3 shows the values of the ROC curve for the Orgasmometer-F. The perceived orgasmic intensity was evaluated by the following sentence: "Considering a Likert scale ranging from 0 to 10, where 0 corresponds to the absence of orgasmic perception and 10 to maximum perceived orgasmic intensity, how do you evaluate your orgasmic intensity in the last six months?". For the dichotomous classification variable, the SD group and control groups were coded as 1 or 0 respectively. The AUC was 0.9 (95% CI 0.871 to 0.924; p <0.0001).

thumbnail
Fig 3. ROC curve analysis.

The analysis was carried out to establish the Orgasmometer-F’s predictive ability to measure the subjective perception of orgasmic intensity.

https://doi.org/10.1371/journal.pone.0202076.g003

Finally, to assess the Orgasmometer-F’s ability to measure low perceived orgasmic intensity, a sensitivity analysis was conducted. A cut-off of<5 was the optimal criterion for differentiating between a low and a high orgasmic intensity. At this cut-off, the sensitivity was 86.5% (95% CI 82,8–89,6), specificity is 80.4% (95% CI 71.8–87.3), Positive Predicted Value (PPV) was 75.4% and Negative Predictive Value (NPV) was 89.5%.

Discussion

There are currently no psychometric tools that specifically measure the intensity of orgasm. For this reason, the aim of this study was to validate the Orgasmometer-F in the female population in order to identify situations in which women with SD might perceive low orgasmic sensations.

Overall, the Orgasmometer-F is a quick, easy tool for evaluating orgasmic intensity in women. It has a high test-retest reliability and high sensitivity, specificity, PPV and NPV. This single-item questionnaire could be used in clinical research to identify orgasmic difficulties related to other sexual dysfunctions and as an additional tool for the FOD diagnosis. In fact, the DSM5 criterion [24] "markedly reduced intensity of orgasmic sensations" in the diagnosis of FOD is evaluated by the personal assessment of the clinician. This study is, to our knowledge, the first to attempt to suggest how the Orgasmometer-F should be used in evaluating female orgasmic disorder.

The usefulness of the Orgasmometer-F in the female population is further supported by the fourth consensus of the International Consultation on Sexual Medicine (ICSM) [41], which proposed a new sexual dysfunction called Hypohedonic Orgasm and defined as “lifelong or acquired decreased or low level of sexual pleasure with orgasm” [41].

The primary endpoint of this study was to determine whether women with sexual dysfunction might perceive diminished orgasmic intensity compared to sexually healthy women. Our data provide quantitative evidence to support this idea.

The low confidence interval of the results obtained with the Orgasmometer-F for the control group of sexually healthy women has important implications. It might be explained by the nature of the instrument: the Orgasmometer-F evaluates orgasmic experience during a six-month period, unlike other questionnaires that limit their investigation to four weeks. This longer time means that women are likely to consider a varying level of pleasurable sensation and sexual satisfaction in answering the questionnaire [10,27]. Conversely, women with sexual dysfunction will report their discomfort in their experience of orgasm [10,24,27]. Moreover, since the female orgasm is a complex product of physical, emotional, cognitive and relational factors, it is reasonable to suppose that the “best” orgasm in women is yet to come. Factors such as anatomy [7,8,16,17,4244], hormonal levels [45], age and sexual experience [46], self-awareness [11,47,48], sexual autonomy (i.e. the extent to which one feels that one’s sexual behaviors are self-determined) [49], ability to lose control during sexual activity [50] and partner-related sexual dysfunctions [51] are closely linked with orgasmic function. However, lacking so far a specific and dedicated psychometric tool, all these studies are not showing qualitative data on female orgasm.

Interestingly, although relational aspects are considered pivotal in the female sexual experience, not being in relationship does not impact on orgasmic experience. In fact, women with orgasmic difficulties tend to approach negatively both in autoerotism and partnered sex. [52,53] Among the factors that negatively affect orgasmic intensity, we identified low scores in the FSFI obvious domains of orgasm and sexual satisfaction but also in the domain of lubrication. This finding fully agrees with the idea that a SD in women is seldom restricted to just one of the phase of sexual response [26,27]. In fact, reduced lubrication can lead women to have difficulty reaching orgasm, to feel it less intensely and in the long term to judge their sexual relationship to be problematic and unsatisfactory. On the other hand, an efficient lubrication leads a woman to focusing better on sexual experience increasing, in a virtuous circle, both sexual desire and arousal [54] and having more probabilities to reach a pleasurable orgasm and feel itself sexually satisfied. In a recent study, over half of women who have difficulty reaching orgasm reported a SD, with greater difficulty in reaching adequate arousal / lubrication, have less sexual desire [54] and longer orgasmic latency times than sexually healthy women. In addition, these women reported less satisfaction in their sexual relationship [27].

Another factor that increases the orgasmic intensity is the adequate masturbatory frequency, quantified as one or more times a week. Autoeroticism in women appears to be associated with a wider repertoire of sexual fantasies and practices, as well as greater ease in reaching arousal and orgasm [55]. Conversely, feelings like shame and sense of guilt about masturbating were found in women with sexual difficulties [55]. Masturbation is a positive component in the structuring of female sexuality and genital sensations, increasing satisfaction in sexual intercourse with partners [48,56]. The findings of the present study are thus consistent with previous evidences, further highlighting the importance of autoerotic experience in sexual self-knowledge.

These findings, which are based on a subjective perception of orgasm, could nevertheless be reinforced with a future comparison of Orgasmometer-F values and objective measures, such as photoplethysmography [57], functional magnetic resonance imaging [58], or with pudendal somatosensory evoked potentials [59].

Limitations

Several limitations in the present study should be noted. The first limitation is its cross-sectional design and lack of hormone testing. However, we are currently considering the effect of reproductive factors, such as menstrual cycle, pregnancy, and puerperium, associated with the intensity of female climax as measured by the Orgasmometer-F.

Furthermore, sexual fantasies were not investigated in this study, which may contribute to a better comprehension of the subjective orgasmic experience in females. We are currently including the investigation of sexual fantasies in the evaluation of orgasmic experience, both in males and females.

Convergent validity was not performed in this study. This is clearly due to a lack of another specific tool in literature to assess orgasmic intensity. Therefore, further investigations could be necessary to verify this aspect.

Lastly, the Internet-based enrollment of subjects presents some selection biases [60,61]. However, since sexuality itself typically represent a research field that can induce embarrassment in the participants, its investigation with Internet studies may reduce these possible negative effects [35, 6266]. Moreover, the main inclusion criteria were the sexual activity, the experience of the orgasm and the ability to fill the FSFI, data that can be easily obtained both with a vis-à-vis interview and with an internet-based questionnaire. Finally, the use of a questionnaire, such as the FSFI, originally validated for auto-administration [29, 67], may mitigate this enrollment bias.

Conclusions

In conclusion, this study demonstrated that female SD is associated with a lower perceived orgasmic intensity. Conversely, some important components of female sexuality such as lubrication, orgasm satisfaction and masturbation, have a positive correlation with perceived orgasmic intensity. The Orgasmometer-F was thus found to be a quick and simple tool for the assessment of the orgasmic experience in the female population.

References

  1. 1. Masters WH, Johnson V. Human sexual response. Boston: Little;1966.
  2. 2. Meston CM, Levin RJ, Sipski ML, Hull EM, Heiman JR. Women's orgasm. Annu Rev Sex Res. 2004, 15: 173–257. pmid:16913280
  3. 3. Bianchi-Demicheli F, Ortigue S. Toward understanding of the central substrates of women's orgasm. Neuropsychologia. 2007; 45: 2645–59. pmid:17543356
  4. 4. Georgiadis JR. Exposing orgasm in the brain: a critical eye. Sex Relat Ther. 2011; 26: 342–55.
  5. 5. Giuliano F, Rampin O, Allard J. Neurophysiology and pharmacology of female genital sexual response. J Sex Marital Ther. 2002; 28: 101–21. pmid:11898692
  6. 6. King R, Belsky J, Mah K, Binik Y. Are there different types of female orgasm? Arch Sex Behav. 2011; 40: 865–75 pmid:20697937
  7. 7. Jannini EA, Rubio-Casillas A, Whipple B, Buisson O, Komisaruk BR, Brody S. Female orgasm(s): one, two, several. J Sex Med. 2012; 9: 956–65. pmid:22462587
  8. 8. Buisson O, Jannini EA. Pilot echographic study of the differences in clitoral involvement following clitoral or vaginal sexual stimulation. J Sex Med. 2013; 10: 2734–40. pmid:23937167
  9. 9. Richters J, Visser Rd, Rissel C, Smith A. Sexual practices at last heterosexual encounter and occurrence of orgasm in a national survey. J Sex Res. 2006; 43: 217–26. pmid:17599244
  10. 10. Fugl-Meyer KS, Oberg K, Lundberg PO, Lewin B, Fugl-Meyer A. On orgasm, sexual techniques, and erotic perceptions in 18- to 74-year-old Swedish women. J Sex Med. 2006; 3: 56–68. pmid:16409218
  11. 11. Burri AV, Cherkas LM, Spector TD. Emotional intelligence and its association with orgasmic frequency in women. J Sex Med. 2009; 6: 1930–7. pmid:19453897
  12. 12. Harris JM, Cherkas LF, Kato BS, Heiman JR, Spector TD. Normal variations in personality are associated with coital orgasmic infrequency in heterosexual women: A population-based study. J Sex Med. 2008; 5: 1177–83. pmid:18331253
  13. 13. Brody S, Costa RM. Vaginal orgasm is associated with less use of immature psychological defense mechanisms. J Sex Med. 2008; 5: 1167–76. pmid:18331263
  14. 14. Bancroft J, Long JS, McCabe J. Sexual well-being: A comparison of U.S. black and white women in heterosexual relationships. Arch Sex Behav. 2011; 40: 725–40. pmid:20953901
  15. 15. Foldes P, Buisson O. The clitoral complex: A dynamic sonographic study. J Sex Med. 2009; 6: 1223–31. pmid:19453931
  16. 16. Buisson O, Foldes P, Jannini E, Mimoun S. Coitus as revealed by ultrasound in one volunteer couple. J Sex Med. 2010; 7: 2750–4. pmid:20626602
  17. 17. Jannini EA, Buisson O, Rubio-Casillas A. Beyond the G—spot: clitourethrovaginal complex anatomy in female orgasm. Nat Rev Urol. 2014; 11: 531–8. pmid:25112854
  18. 18. Roslan NS, Jaafar NRN, Sidi H, Baharuddin N, Kumar J, Das S, et al. The Bio-Psycho-Social Dimension In Women's Sexual Desire: 'Argumentum Ad Novitatem'. Curr Drug Targets. 2017; Jun 21. [Epub ahead of print]
  19. 19. Sidi H, Midin M, Puteh SE, Abdullah N. Orgasmic dysfunction among women at a primary care setting in Malaysia. Asia Pac J Public Health. 2008; 20: 298–306. pmid:19124324
  20. 20. Mah K, Binik YM. Are orgasms in the mind or the body? Psychosocial versus physiological correlates of orgasmic pleasure and satisfaction. J Sex Marital Ther. 2005; 31: 187–200. pmid:16020138
  21. 21. Davidson JK, Darling CA. Self-perceived differences in the female orgasmic response. Fam Pract Res. J 1989; 8: 75–84. pmid:2741728
  22. 22. Dove NL, Wiederman MW. Cognitive distraction and women's sexual functioning. J Sex Marital Ther. 2000; 26: 67–78. pmid:10693117
  23. 23. Lavie-Ajayi M, Joffe H. Social representations of female orgasm. J Health Psychol. 2009; 14: 98–107. pmid:19129342
  24. 24. Graham CA. The DSM diagnostic criteria for female orgasmic disorder. Arch Sex Behav. 2010; 39: 256–70. pmid:19784768
  25. 25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.
  26. 26. World Health Organization. International statistical classification of diseases and related health problems. 10th ed. Geneva: World Health Organization; 1992.
  27. 27. Rowland DL, Kolba TN. Understanding Orgasmic Difficulty in Women. J Sex Med. 2016; 13: 1246–54. pmid:27345217
  28. 28. Giraldi A, Rellini A, Pfaus JG, Bitzer J, Laan E, Jannini EA, et al. Questionnaires for assessment of female sexual dysfunction: A review and proposal for a standardized screener. J Sex Med. 2011; 8: 2681–706. pmid:21810182
  29. 29. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005; 31: 1–20. pmid:15841702
  30. 30. Maseroli E, Fanni E, Fambrini M, Ragghianti B, Limoncin E, Mannucci E, et al. Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction. J Endocrinol Invest. 2016; 39: 401–9. pmid:26335300
  31. 31. Quirk FH, Haughie S, Symonds T. The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction. J Sex Med. 2005; 2: 469–77. pmid:16422841
  32. 32. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: Psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav. 1994; 23: 627–43. pmid:7872859
  33. 33. Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 2006; 32: 43–52. pmid:16234225
  34. 34. Dubray S, Gérard M, Beaulieu-Prévost D, Courtois F. Validation of a Self-Report Questionnaire Assessing the Bodily and Physiological Sensations of Orgasm. J Sex Med. 2017; 14: 255–63. pmid:28161081
  35. 35. Limoncin E, Lotti F, Rossi M, Maseroli E, Gravina GL, Ciocca G, et al. The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardization of the ‘Orgasmometer’. Andrology. 2016; 4: 921–6. pmid:27214119
  36. 36. Filocamo MT, Serati M, Li Marzi V, Costantini E, Milanesi M, Pietropaolo A, et al. The Female Sexual Function Index (FSFI): linguistic validation of the Italian version. J Sex Med. 2014; 11: 447–53. pmid:24224761
  37. 37. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (Text-Revised). Washington, DC: American Psychiatric Press; 2000.
  38. 38. Ferreira-Valente MAet al. Validity of fourpain intensity-rating scales. Pain. 2011; 152: 2399–404. pmid:21856077
  39. 39. Altman DG. Practical statistics for medical research. London: Chapman & Hall/CRC; 1999.
  40. 40. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837–45. pmid:3203132
  41. 41. McCabe MP et al. Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016; 13: 135–43. pmid:26953828
  42. 42. D'Amati G, di Gioia CR, Bologna M, Giordano D, Giorgi M, Dolci S, et al. Type 5 phosphodiesterase expression in the human vagina. Urology. 2002; 60: 191–5. pmid:12100961
  43. 43. D'Amati G, di Gioia CR, Proietti Pannunzi L, Pistilli D, Carosa E, Lenzi A, et al. Functional anatomy of the human vagina. J Endocrinol Invest. 2003; 26: 92–6.
  44. 44. Gravina GL, Brandetti F, Martini P, Carosa E, Di Stasi SM, Morano S, et al. Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm. J Sex Med. 2008; 5: 610–8. pmid:18221286
  45. 45. Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, Jannini EA. Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychother Psychosom. 2007; 76: 134–140. pmid:17426412
  46. 46. Kinsey AC, Pomeroy WB, Martin CE. Sexual behaviour in the human female. Philadelphia: WB Sanders Co; 1953.
  47. 47. Herbenick D, Reece M. Development and validation of the female genital self-image scale. J Sex Med. 2010; 7: 1822–30. pmid:20233278
  48. 48. Salisbury CM, Fisher WA. "Did you come?" A qualitative exploration of gender differences in beliefs, experiences, and concerns regarding female orgasm occurrence during heterosexual sexual interactions. J Sex Res. 2014; 51: 616–31. pmid:24350619
  49. 49. Laan E, Rellini AH. Can we treat anorgasmia in women? The challenge to experiencing pleasure. Sex Rel Ther. 2011; 26: 329–41.
  50. 50. Bancroft JHJ. Human sexuality and its problems. Oxford: Churchill Livingstone; 2009.
  51. 51. Maseroli E, Fanni E, Mannucci E, Fambrini M, Jannini EA, Maggi M, et al. Which are the male factors associated with female sexual dysfunction (FSD)? Andrology. 2016; 4: 911–20. pmid:27409983
  52. 52. Rowland DL, Medina MC, Dabbs CR. Attribution Patterns in Women with and without Orgasmic Difficulties. J Sex Res. 2017 [Epub ahead of print].
  53. 53. Rowland DL, Cempel LM, Tempel AR. Women's Attributions Regarding Why They Have Difficulty Reaching Orgasm. J Sex Marital Ther. 2018 [Epub ahead of print].
  54. 54. Jafaar NRN, Midin M, Puteh SEW, Musa R, Sidi H. Sexual Desire and Sexual Arousal in Malaysian Women: Are They of The Same Entity? ASEAN J Psych. 2009; 10: 43–53.
  55. 55. Carvalheira A, Leal I. Masturbation among women: associated factors and sexual response in a Portuguese community sample. J Sex Marital Ther. 2013; 39: 347–67. pmid:23421789
  56. 56. Brody S, Fischer AH, Hess U. Women's finger sensitivity correlates with partnered sexual behavior but not solitary masturbation frequencies. J Sex Marital Ther. 2008; 34: 343–52. pmid:18576235
  57. 57. Meston CM, Rellini AH, McCall K. The sensitivity of continuous laboratory measures of physiological and subjective sexual arousal for diagnosing women with sexual arousal disorder. J Sex Med. 2010; 7: 938–50. pmid:20487501
  58. 58. Komisaruk BR, Whipple B. Functional MRI of the brain during orgasm in women. Annu Rev Sex Res. 2005; 16: 62–86. pmid:16913288
  59. 59. Yang CC, Bowen JR, Kraft GH, Uchio EM, Kromm BG. Cortical evoked potentials of the dorsal nerve of the clitoris and female sexual dysfunction in multiple sclerosis. J Urol. 2000; 164: 2010–3. pmid:11061904
  60. 60. Lane TS, Armin J, Gordon JS. Online Recruitment Methods for Web-Based and Mobile Health Studies: A Review of the Literature. J Med Internet Res. 2015; 17: e183. pmid:26202991
  61. 61. Hatch EE, Hahn KA, Wise LA, Mikkelsen EM, Kumar R, Fox MP, et al. Evaluation of Selection Bias in an Internet-based Study of Pregnancy Planners. Epidemiology. 2016; 27: 98–104. pmid:26484423
  62. 62. Enquist M, Aronsson H, Ghirlanda S, Jansson L, Jannini EA. Exposure to mother's pregnancy and lactation in infancy is associated with sexual attraction to pregnancy and lactation in adulthood. J Sex Med. 2011; 8: 140–7. pmid:20946158
  63. 63. Jannini EA, Limoncin E, Ciocca G, Buehler S, Krychman M. Ethical aspects of sexual medicine. Internet, vibrators, and other sex aids: toys or therapeutic instruments? J Sex Med. 2012; 9: 2994–3001. pmid:23206344
  64. 64. Limoncin E, Carta R, Gravina GL, Carosa E, Ciocca G, Di Sante S, et al. The sexual attraction toward disabilities: a preliminary internet-based study. Int J Impot Res. 2014; 26: 51–4. pmid:24048013
  65. 65. Limoncin E, Tomassetti M, Gravina GL, Ciocca G, Carosa E, Di Sante S, et al. Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress. J Urol. 2013; 189: 1830–5. pmid:23142691
  66. 66. Limoncin E, Galli D, Ciocca G, Gravina GL, Carosa E, Mollaioli D, et al. The psychosexual profile of sexual assistants: an internet-based explorative study. PLoS One. 2014; 9: e98413. pmid:24919176
  67. 67. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003; 29: 39–46. pmid:12519665